Laughner et al. also showed that HER2 signaling, induced by overexpression in mouse 3T3 cells or heregulin-β1 stimulation of human MCF-7 breast cancer cells, resulted in increased HIF-1α expression and, consequently, VEGF mRNA expression [74]. This evidence concerns the gene ERBB2 and breast carcinoma.